Understanding Bone Health in Patients with Prostate Cancer
Speakers: Neal D. Shore, MD, FACSJorge A. Garcia, MD, FACP
Duration: 60 minutes
Presented on: June 10, 2020
*This session is not eligible for AMA PRA Category 1 CreditsTM
Neal D. Shore, MD, FACS
Neal D. Shore, MD, FACSNeal D. Shore, MD, FACS is the Medical Director for the Carolina Urologic Research Center. He practices with Atlantic Urology Clinics in Myrtle Beach, South Carolina.
Dr. Shore has conducted more than 350 clinical trials, focusing mainly on GU Oncology, and serves on the Executive Boards of: Society of Urologic Oncology Board, Bladder Cancer Advocacy Network, and is Immediate Past President, Large Urology Group Practice Association. He is a founder for both: CUSP Clinical Trials Consortium, as well as for DASHKO, large urology practices data registries. He serves as the National Urology Research Director for 21st Century Oncology. He has served on the AUA Male Health Committee and the AUA Data Committee, the SITC Task Force for Prostate Cancer, the Bladder Cancer Advocacy Think Tank and the editorial boards of Reviews in Urology, Urology Times, Chemotherapy Advisor, OncLive, PLOS ONE(Academic Editor), Urology Practice, World Journal of Urology, and serves as Editor, Everyday Urology-Oncology. He has more than 175 peer reviewed publications and numerous book chapters; he performs peer review for Lancet Oncology, New England Journal of Medicine, European Urology, Journal Urology, Urology, BJUI, PCPD, and numerous other high impact scientific journals.
A graduate of Duke University and Duke University Medical School, Dr. Shore completed a 6-month clinical research fellowship in Pretoria, South Africa, and then completed his General Surgery/Urology training at New York Hospital Cornell Medical Center and at Memorial Sloan-Kettering Cancer Center in New York City. He is a Fellow of the American College of Surgeons.
Jorge A. Garcia, MD, FACP
Jorge A. Garcia, MD, FACPJorge A. Garcia, MD., FACP, is The Kerscher Family Chair for Clinical Prostate Cancer Research at the Cleveland Clinic. Dr. Garcia is a staff physician and member of the Department of Hematology and Oncology and Urology at the Cleveland Clinic’s Taussig Cancer Institute and Glickman Urological & Kidney Institute. Dr. Garcia’s work focuses on clinical and translational research in genitourinary malignancies. He is the current director of the advanced prostate cancer research program at the Cleveland Clinic. He is an Associate Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University in Cleveland, Ohio. Currently Dr Garcia also serves as a member on the oncology drugs advisory committee (ODAC) of the food and drug administration (FDA).
Dr. Garcia earned his medical degree at the Colombian School of Medicine in Bogota, Colombia. After completing a Cancer Biology Fellowship at Harvard Medical School, Dr. Garcia completed his training in Internal Medicine at the Albert Einstein College of Medicine in New York. Subsequently, Dr. Garcia was awarded a fellowship in hematology and oncology and Urologic Oncology at the University of California San Francisco.
Certified in Medical Oncology and Internal Medicine by the American Board of Internal Medicine, Dr. Garcia’s primary research at the Cleveland Clinic has been in prostate, kidney and bladder cancer, with special focus on developmental therapeutics and immunotherapy. Dr. Garcia’s has authored over 250 manuscripts and his research has been published in peer-reviewed journals that include New England Journal of Medicine, Clinical Cancer Research, Journal of Clinical Oncology, Journal of the National Cancer Institute, Lancet Oncology, Journal of Urology, Cancer and BJU International among others. He is an associate editor for several journals focused in GU oncology and a reviewer for several cancer journals including, Clinical Cancer Research, Cancer, Urology, Annals of Oncology, Journal of Clinical Oncology, Clinical and Experimental Medicine and the BJU.
Dr. Garcia is a Fellow of the American College of Physicians and served as a relevance reviewer for the American Board of Internal Medicine. He is also the director of the clinical research office at the Comprehensive Cancer Center at Case Western Reserve University. Dr. Garcia has also been listed among the best doctors in Cleveland and the United Stated every year since 2009.
Disclosures: In the past two years, Dr. Garcia has served as a paid speaker/consultant and/or advisor for Clovis, Janssen, Sanofi, Genentech, Pfizer, Bayer, Eisai, Astellas Pharma and Merck. His institution has received research funding from Pfizer, Astellas Pharma, Orion Pharma, Bayer, Janssen Oncology, and Genentech/Roche, Merck and Clovis.